A detailed history of Nissay Asset Management Corp transactions in Incyte Corp stock. As of the latest transaction made, Nissay Asset Management Corp holds 21,896 shares of INCY stock, worth $1.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,896
Previous 21,482 1.93%
Holding current value
$1.33 Million
Previous $1.35 Million 7.49%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $23,411 - $27,568
414 Added 1.93%
21,896 $1.25 Million
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $51,794 - $63,740
993 Added 4.85%
21,482 $1.35 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $40,670 - $46,414
704 Added 3.56%
20,489 $1.18 Million
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $13,835 - $17,140
-227 Reduced 1.13%
19,785 $1.23 Million
Q1 2023

May 15, 2023

SELL
$70.23 - $86.01 $58,009 - $71,044
-826 Reduced 3.96%
20,012 $1.45 Million
Q4 2022

Feb 14, 2023

SELL
$67.18 - $84.11 $13,503 - $16,906
-201 Reduced 0.96%
20,838 $1.67 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $55,326 - $69,270
836 Added 4.14%
21,039 $1.4 Million
Q2 2022

Aug 15, 2022

SELL
$66.18 - $83.18 $19,787 - $24,870
-299 Reduced 1.46%
20,203 $1.54 Million
Q1 2022

May 16, 2022

BUY
$66.02 - $79.71 $24,493 - $29,572
371 Added 1.84%
20,502 $1.63 Million
Q4 2021

Feb 14, 2022

BUY
$63.34 - $74.11 $68,470 - $80,112
1,081 Added 5.67%
20,131 $1.48 Million
Q3 2021

Nov 10, 2021

SELL
$68.67 - $84.02 $43,193 - $52,848
-629 Reduced 3.2%
19,050 $1.31 Million
Q2 2021

Aug 13, 2021

BUY
$79.87 - $87.53 $42,171 - $46,215
528 Added 2.76%
19,679 $1.66 Million
Q1 2021

May 11, 2021

SELL
$76.02 - $100.5 $13.8 Million - $18.2 Million
-181,418 Reduced 90.45%
19,151 $1.56 Million
Q4 2020

Feb 08, 2021

SELL
$80.74 - $97.7 $5.27 Million - $6.37 Million
-65,222 Reduced 24.54%
200,569 $17.4 Million
Q3 2020

Oct 20, 2020

BUY
$85.07 - $109.69 $3.82 Million - $4.92 Million
44,864 Added 20.31%
265,791 $23.9 Million
Q2 2020

Jul 27, 2020

SELL
$74.18 - $108.93 $798,176 - $1.17 Million
-10,760 Reduced 4.64%
220,927 $23 Million
Q1 2020

May 05, 2020

BUY
$63.18 - $85.97 $5.16 Million - $7.02 Million
81,678 Added 54.45%
231,687 $17 Million
Q4 2019

Feb 14, 2020

BUY
$73.04 - $95.72 $1.5 Million - $1.96 Million
20,494 Added 15.82%
150,009 $13.1 Million
Q3 2019

Nov 14, 2019

SELL
$72.82 - $86.52 $2.42 Million - $2.87 Million
-33,219 Reduced 20.41%
129,515 $9.61 Million
Q2 2019

Aug 07, 2019

BUY
$73.52 - $88.7 $10.9 Million - $13.2 Million
148,332 Added 1029.94%
162,734 $13.8 Million
Q1 2019

May 03, 2019

BUY
$63.56 - $88.17 $50,784 - $70,447
799 Added 5.87%
14,402 $1.24 Million
Q4 2018

Feb 06, 2019

BUY
$58.5 - $69.94 $34,807 - $41,614
595 Added 4.57%
13,603 $865,000
Q3 2018

Oct 30, 2018

BUY
$61.75 - $74.23 $28,528 - $34,294
462 Added 3.68%
13,008 $899,000
Q2 2018

Aug 08, 2018

SELL
$60.85 - $83.98 $611,299 - $843,663
-10,046 Reduced 44.47%
12,546 $841,000
Q1 2018

May 14, 2018

BUY
$83.06 - $100.98 $57,394 - $69,777
691 Added 3.16%
22,592 $1.88 Million
Q4 2017

Feb 14, 2018

BUY
$93.56 - $116.6 $2.05 Million - $2.55 Million
21,901
21,901 $2.08 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $13.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.